Increased leucocyte oxidative metabolism in hyperlipoproteinaemia

Area of Science:

• Biochemistry
• Immunology
• Clinical Medicine

Background:

• Hyperlipoproteinaemia (HLP) is associated with cardiovascular risks.
• Oxidative stress plays a role in various chronic diseases.
• Polymorphonuclear leucocytes (PMN) are key immune cells involved in inflammation.

Purpose of the Study:

• To investigate the oxidative metabolism of PMN in hyperlipoproteinaemia (HLP).
• To determine the relationship between PMN oxidative activity and lipid levels.
• To assess the impact of lipid-lowering treatment on PMN function in HLP.

Main Methods:

• Compared superoxide anion (O2-) release, hexose monophosphate shunt activity, and chemiluminescence of PMN from HLP subjects and controls.
• Correlated PMN oxidative metabolism markers with serum lipid levels (cholesterol, LDL-cholesterol).
• Evaluated PMN oxidative metabolism in HLP subjects before and after cholestyramine treatment.

Main Results:

• PMN from HLP subjects showed significantly higher O2- release, hexose monophosphate shunt activity, and chemiluminescence compared to controls.
• PMN O2- release was positively correlated with serum cholesterol and LDL-cholesterol levels.
• Cholestyramine treatment, which lowered lipid levels in HLP subjects, normalized their PMN oxidative metabolism.

Conclusions:

• HLP is associated with enhanced PMN oxidative metabolism and superoxide anion production.
• Elevated lipid levels in HLP contribute to increased PMN oxidative activity.
• Restoration of normal lipid profiles through treatment can normalize PMN oxidative metabolism, suggesting a causal relationship.